revenue recognition

Babcock & Wilcox faces securities class action alleging false statements about major power generation contract. Investors have until June 15, 2026 deadline to seek compensation.

Babcock & Wilcox faces class action lawsuit alleging false statements about Applied Digital contract. Claims largest shareholder had conflicting interests; investors can join through June 15.

Rosen Law Firm urges $BW investors to secure counsel before June 15 deadline in securities class action alleging false statements about Applied Digital contract.

Robbins LLP files class action against Babcock & Wilcox ($BW) over alleged investor deception regarding shareholder relationships and contract legitimacy, exposing alleged disclosure failures from November 2025-March 2026.

Rosen Law Firm alerts Babcock & Wilcox investors of June 15 deadline in securities class action alleging false statements about Applied Digital contract and undisclosed shareholder ties.

Veritone faces securities investigation after restating $2.48M in revenue overstatements, triggering 37% cumulative stock decline.

Rosen Law Firm urges $BW investors to join class action lawsuit alleging false statements regarding Applied Digital power generation contract before June 15 deadline.

ADMA Biologics shares crashed 16% after short seller accused the company of inflating revenues through improper rebates and extended payment terms to distributors.

$DRVN faces class action lawsuit alleging undisclosed accounting errors spanning lease recordings, revenue recognition, and balance sheet misclassifications from May 2023 to February 2026.

Driven Brands ($DRVN) stock crashed 30.2% after revealing accounting errors spanning 2023. Class action lawsuit filed; investors have until May 8, 2026 to join.

Driven Brands disclosed material accounting errors spanning 2023-present, triggering 30% stock collapse and securities fraud class action with May 8 deadline.

Driven Brands disclosed material accounting errors spanning 2023-2026, including improper revenue recognition and cash discrepancies. Stock crashed 30.2% to $11.60, triggering shareholder litigation.

Driven Brands ($DRVN) stock plummets 30.2% after disclosing multi-year accounting errors. Class action deadline set for May 8, 2026.

Driven Brands faces securities fraud class action over material accounting errors spanning 2023-2026. Stock fell 30.2% following disclosure.

Driven Brands faces securities fraud class action after disclosing accounting errors spanning 2023-2026, triggering a 30.2% stock collapse. Shareholders can file lead plaintiff motions by May 8, 2026.

Driven Brands faces class action lawsuit after disclosing material accounting errors in fiscal 2023-2025 financial statements. Stock fell 30% following the restatement announcement.

Driven Brands stock plummets 40% after restating financials due to multi-year accounting errors including improper revenue recognition and lease accounting. Securities fraud probe launched.

CRISPR stock rallied 12% on pipeline momentum despite quarterly losses and minimal revenue, buoyed by cash reserves and CTX611 candidate progress.

ICON's Audit Committee investigates revenue recognition control deficiencies from 2023-2025. Stock plunged 40% after disclosure; company delayed financials and withdrew 2025 guidance.